TIPS-11 EFFICACY AND SAFETY OF STUPP REGIMEN WITH OR WITHOUT ANLOTINIB FOR NEWLY DIAGNOSED GLIOBLASTOMA: INTERIM RESULTS OF A MULTICENTER, DOUBLEBLIND, RANDOMIZED PHASE II TRIAL

BACKGROUND: Postoperative radiotherapy with concomitant temozolomide (TMZ) followed by ≤ six cycles of adjuvant TMZ chemotherapy (STUPP regimen) is the standard treatment for newly diagnosed glioblastoma (GBM) with limited effectiveness. Anlotinib inhibits both tumor angiogenesis and tumor cell prol...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuanyuan, Liu, Guihong, Li, Meihua, Wang, Liang, Sun, Pengfei, Chen, Zhongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Trials in Progress
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402405/
http://dx.doi.org/10.1093/noajnl/vdad070.142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402405/
http://dx.doi.org/10.1093/noajnl/vdad070.142

Ejemplares similares